Calithera Biosciences (NASDAQ:CALA) Shares Cross Above 50-Day Moving Average – Should You Sell?

Calithera Biosciences, Inc. (NASDAQ:CALAGet Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Calithera Biosciences shares last traded at $0.00, with a volume of 10,659 shares.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Calithera Biosciences in a research report on Friday. They set a “hold” rating for the company.

Get Our Latest Report on CALA

Calithera Biosciences Price Performance

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Featured Stories

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.